Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)

Market Cap	8.77B
Revenue (ttm)	2.92B
Net Income (ttm)	-1.35B
Shares Out	995.27M
EPS (ttm)	-1.32
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,266,084
Average Volume	150,227,761
Open	8.27
Previous Close	8.81
Day's Range	8.27 - 9.03
52-Week Range	3.13 - 10.27
Beta	0.51
RSI	60.03
Earnings Date	Aug 25, 2025

About SHE:300158

Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research and development, production, and sales of pharmaceutical drugs in China and internationally. It offers drugs for various fields, including cancer, cardiovascular, infectious disease, antibiotics, cardiocerebrovascular, antitumor, gastrointestinal, and respiratory, as well as urinary, tonic, dermatology, blood hematopoietic, digestion, urology, and heart and brain; vitamins; Chinese medicines in the form of pills, tablets, capsules, powders, and granu...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 3,720
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300158

Financial Performance

In 2024, SHE:300158's revenue was 2.97 billion, a decrease of -18.06% compared to the previous year's 3.63 billion. Losses were -1.33 billion, 2920.6% more than in 2023.